ARTAVNEA Trademark

Trademark Overview

On Monday, November 28, 2016, a trademark application was filed for ARTAVNEA with the United States Patent and Trademark Office. The USPTO has given the ARTAVNEA trademark a serial number of 87248829. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 20, 2020. This trademark is owned by Pfizer Inc.. The ARTAVNEA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use
artavnea

General Information

Serial Number87248829
Word MarkARTAVNEA
Filing DateMonday, November 28, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 20, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations for use in hematology; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations, and tissue repair preparations; vaccines for human use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, December 2, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, July 20, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, July 20, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, November 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2019EXTENSION 5 GRANTED
Wednesday, November 13, 2019EXTENSION 5 FILED
Monday, November 18, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 13, 2019TEAS EXTENSION RECEIVED
Monday, November 4, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, October 31, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 31, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, June 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 3, 2019EXTENSION 4 GRANTED
Monday, June 3, 2019EXTENSION 4 FILED
Monday, June 3, 2019TEAS EXTENSION RECEIVED
Wednesday, November 21, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 19, 2018EXTENSION 3 GRANTED
Monday, November 19, 2018EXTENSION 3 FILED
Monday, November 19, 2018TEAS EXTENSION RECEIVED
Wednesday, May 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 7, 2018EXTENSION 2 GRANTED
Monday, May 7, 2018EXTENSION 2 FILED
Monday, May 7, 2018TEAS EXTENSION RECEIVED
Wednesday, November 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 30, 2017EXTENSION 1 GRANTED
Monday, October 30, 2017EXTENSION 1 FILED
Monday, October 30, 2017TEAS EXTENSION RECEIVED
Tuesday, June 13, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 18, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2017PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, March 3, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 2, 2017ASSIGNED TO EXAMINER
Friday, December 2, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 1, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

artavnea preparations pharmaceutical dysfunction treatment cancer diabetes sexual pain disorders diseases